The existence of a local renin-angiotensin system (RAS) in neurons was first postulated 40 years ago. Further studies indicated intraneuronal generation of ANG II. However, the function and signaling mechanisms of intraneuronal ANG II remained elusive. Since ANG II type 1 receptor (AT1R) is the major type of receptor mediating the effects of ANG II, we used intracellular microinjection and concurrent Ca 2ϩ and voltage imaging to examine the functionality of intracellular AT1R in neurons. We show that intracellular administration of ANG II produces a dose-dependent elevation of cytosolic Ca 2ϩ concentration ([Ca 2ϩ ]i) in hypothalamic neurons that is sensitive to AT1R antagonism. Endolysosomal, but not Golgi apparatus, disruption prevents the effect of microinjected ANG II on [Ca 2ϩ ]i. Additionally, the ANG II-induced Ca 2ϩ response is dependent on microautophagy and sensitive to inhibition of PLC or antagonism of inositol 1,4,5-trisphosphate receptors. Furthermore, intracellular application of ANG II produces AT1R-mediated depolarization of hypothalamic neurons, which is dependent on [Ca 2ϩ ]i increase and on cation influx via transient receptor potential canonical channels. In summary, we provide evidence that intracellular ANG II activates endolysosomal AT1Rs in hypothalamic neurons. Our results point to the functionality of a novel intraneuronal angiotensinergic pathway, extending the current understanding of intracrine ANG II signaling.
calcium; endoplasmic reticulum; renin-angiotensin system THE RENIN-ANGIOTENSIN SYSTEM (RAS) exists not only as a circulating hormonal system regulating blood pressure and water/electrolyte homeostasis, but also as a local system, with important physiological/pathophysiological implications in several organs, including the brain (32, 47) . In addition, increasing evidence supports the existence of an intracellular RAS, converging to intracellular synthesis and action of ANG II (14, 29) . Whether systemic, local, or intracellular, the central effector peptide of RAS is ANG II, formed by sequential cleavage of angiotensinogen by renin and angiotensin-converting enzyme/chymase. The ANG II type 1 receptor (AT 1 R) is the main G protein-coupled receptor (GPCR) mediating the effects of ANG II (15) .
With respect to neurons, increasing evidence supports neuronal synthesis of angiotensinogen and intraneuronal generation of ANG II, particularly in hypothalamic nuclei involved in cardiovascular control (22) . An intracellular, nonsecreted form of renin is present in neurons and may be involved in intraneuronal synthesis of angiotensin peptides (22, 40) . ANG II has been detected in the cell bodies and fibers of several hypothalamic nuclei (22, 40) ; association of ANG II with intraneuronal vesicles has also been reported (22, 40) . AT 1 Rs are expressed in the hypothalamus (1, 33) . AT 1 Rs may signal through different second messengers by coupling to different G proteins (15) . Coupling of AT 1 Rs to G q/11 proteins induces Ca 2ϩ -dependent responses (42) .
Despite compelling evidence supporting the physiological and/or pathophysiological relevance of the brain RAS in cardiovascular control, thirst, memory facilitation, and metabolism (3, 40, 47) , the functional significance of intracellular ANG II in neurons remains to be established. We and others have characterized effects mediated by intracellular ANG II in other tissues such as myometrium (17) and vascular smooth muscle cells (8, 25) . Therefore, in the present study, we used intracellular microinjection and concurrent imaging to characterize intracellular ANG II-mediated signaling in hypothalamic neurons. 1 
MATERIALS AND METHODS
Ethical approval. Animal protocols were approved by the Institutional Animal Care and Use Committee.
Chemicals. Bafilomycin A1, brefeldin A, ryanodine, and xestospongin C were obtained from EMD Millipore (Billerica, MA); ANG II, heparin, rapamycin, U-73122, SKF-96365, BAPTA-AM, 1-oleoyl-2-acetyl-sn-glycerol (OAG), and CV-11947 (candesartan) from SigmaAldrich (St. Louis, MO); and Ned-19 and PD-123319 ditrifluoroacetate from Tocris Bioscience (R & D Systems, Minneapolis, MN). Rat AT1R in pIRES2 DsRed-Express2 vector (AT1R-DsRed) plasmid cDNA and control empty vector (DsRed) were provided by Dr. Satoru Eguchi. To create mammalian expression, the vector encoding rat AT1aR-hemagglutinin and independent red fluorescent protein, the polymerase chain reaction product of rat AT1aR cDNA fused with NH2-terminal hemagglutinin (18) in pcDNA3 vector (kindly provided by Dr. Laszlo Hunyady), was ligated into pIRES2 DsRed-Express2 vector (Clontech, Mountain View, CA).
DNA constructs and transfection. U2OS cells (American Type Culture Collection, Manassas, VA) were cultured in DMEM (Mediatech, Herndon, VA) containing 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA). U2OS cells were transiently transfected with DsRed and DsRed-tagged rat AT1R (AGTRA_RAT, primary accession no. P25095) using TurboFectin 8.0 according to the manufacturer's protocol (OriGene Technologies, Rockville, MD). Cells were used 24 -48 h after transfection.
Neuronal cell culture. Hypothalamic neurons were dissociated from neonatal (1-to 2-day-old) Sprague-Dawley rats (Ace Animal, Boyertown, PA) of both sexes, as previously described (7) . Newborn rats were decapitated, and brains were quickly removed surgically and immersed in ice-cold Hanks' balanced salt solution (HBSS; Mediatech). The hypothalamus was identified, removed, minced, and subjected to enzymatic digestion (papain, 5 min, 37°C) and mechanical trituration in the presence of total medium [Neurobasal-A (Invitrogen, Carlsbad, CA) containing 1% GlutaMAX (Invitrogen), 2% penicillinstreptomycin-amphotericin B solution (Mediatech), and 10% fetal bovine serum]. Cells were cultured on round 25-mm glass coverslips coated with poly-L-lysine (Sigma-Aldrich) in six-well plates. Cultures were maintained at 37°C in a humidified atmosphere with 5% CO 2. The mitotic inhibitor cytosine ␤-arabinofuranoside (1 M; SigmaAldrich) was added to the culture on day 3 to inhibit glial cell proliferation.
Immunocytochemistry and confocal imaging studies. At 48 h after hypothalamic neurons were transiently transfected with DsRed-tagged rat AT 1R and green fluorescent protein (GFP)-Rab7 (Addgene, Cambridge MA) using TurboFectin 8.0 according to the manufacturer's protocol, they were fixed with 4% paraformaldehyde, washed in PBS, and mounted with Dapi-Fluoromont-G (Southern Biotech, Birmingham, AL). Cells were imaged using a two-photon confocal microscope (model 710, Carl Zeiss) with a ϫ63 oil-immersion objective and ϫ1 digital zoom, with excitations set for 4=,6-diamidino-2-phenylindole, GFP, and DsRed at 405, 488, and 561 nm, respectively. Images were analyzed using ZEN 2010 (Zeiss), as previously reported (28, 49) . Ca 2ϩ imaging. Intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) was measured as previously described (7, 9, 16, 17, 49) . Cells were . During the experiments, the Perfect Focus System was activated. Fura 2-AM fluorescence (510-nm emission), following alternate excitation at 340 and 380 nm, was acquired at a frequency of 0.25 Hz. Images were acquired and analyzed using NIS-Elements AR 3.1 software (Nikon). The ratio of the fluorescence signal at 340 nm to that at 380 nm was converted to Ca 2ϩ concentration (24) . In Ca 2ϩ -free experiments, CaCl2 was omitted. Intracellular microinjection. Intracellular microinjections were performed using FemtotipsII, InjectMan NI 2, and FemtoJet systems (Eppendorf), as described elsewhere (9, 16, 17, 49) . Pipettes were backfilled with an intracellular solution containing (in mM) 110 KCl, 10 NaCl, and 20 HEPES (pH 7.2) or the compounds to be tested. Injection time was 0.4 s at 60 hPa with a compensation pressure of 20 hPa to maintain the microinjected volume to Ͻ1% of cell volume, as measured by microinjection of a fluorescent compound (fura 2-free acid). The intracellular concentration of chemicals was determined on the basis of the concentration in the pipette and the volume of injection. The cells to be injected were Z-scanned before injection, and the cellular volume was automatically calculated using NISElements AR 3.1 software.
Measurement of membrane potential. The relative changes in membrane potential (V m) of single neurons were evaluated using bis-(1,3-dibutylbarbituric acid)trimethine oxonol [DiBAC4(3)], a slow-response voltage-sensitive dye, as previously described (49) . Upon membrane hyperpolarization, the dye concentrates in the cell membrane, leading to a decrease in fluorescence intensity, while depolarization induces sequestration of the dye into the cytosol, resulting in an increase in the fluorescence intensity. Cultured hypothalamic neurons were incubated for 30 min in HBSS containing 0.5 mM DiBAC 4(3), and fluorescence was monitored at 0.17 Hz and 480-nm excitation/540-nm emission. Calibration of DiBAC4(3) fluorescence following background subtraction was performed using the Na ϩ -K ϩ ionophore gramicidin in Na ϩ -free physiological solution and various concentrations of K ϩ (to alter Vm) and N-methylglucamine (to maintain osmolarity). Under these conditions, Vm was approximately equal to the K ϩ equilibrium potential determined by the Nernst equation. The intracellular K ϩ and Na ϩ concentrations were assumed to be 130 and 10 mM, respectively.
Data analysis. Values are means Ϯ SE. One-way ANOVA followed by post hoc Bonferroni's and Tukey's tests was used to assess significant differences between groups. P Ͻ 0.05 was considered statistically significant. (51) [Ca 2ϩ ] i in untransfected U2OS cells. Similarly, in DsRedtransfected U2OS cells, intracellular administration of control buffer or ANG II had no effect. Also, microinjection of the AT 1 R antagonist CV-11947 or the AT 2 R antagonist PD-123319 (both 10 Ϫ7 M) did not elicit significant [Ca 2ϩ ] i increases in AT 1 R-transfected U2OS cells or neurons. Six cells were injected in each of the above-mentioned control experiments. Data are presented in Table 1 . ] i by 258 Ϯ 11, 711 Ϯ 8, and 972 Ϯ 17 nM, respectively (n ϭ 6 cells for each concentration; Fig. 1, A-D ] i ϭ 697 Ϯ 7 nM, n ϭ 6; Fig. 1, A, B , E, and F). Neither antagonist alone had an effect on its own when injected into AT 1 R-transfected U2OS cells (Table 1) . ] i : 197 Ϯ 6 nM (n ϭ 6 of 34), 398 Ϯ 7 nM (n ϭ 6 of 29), and 605 Ϯ 9 nM (n ϭ 6 of 32), respectively (Fig. 2, A-D (Fig. 2, A, B, E, and F) . ] i ϭ 411 Ϯ 9 nM, n ϭ 6 of 36 neurons; Fig. 3, A and B) . Nevertheless, the ANG II effect was largely abolished by 1 h of incubation with bafilomycin A 1 (1 M), a V-type ATPase inhibitor that prevents lysosomal acidification (6), or rapamycin (30 M), an agent that blocks microautophagy (30) (Fig. 3, A and  B) . Endolysosomal location of AT 1 R in neurons was confirmed by colocalization of AT 1 R-DsRed with Rab7-GFP, a small GTPase associated with endosomes and lysosomes (45) (Fig. 3C) . lamic neurons were also distinct, albeit the difference was more pronounced (626 Ϯ 26 and 368 Ϯ 11, respectively , Fig.  4B) ; the half-lives were largely identical (Fig. 4C) .
RESULTS

Similar to previous reports
: ⌬[Ca 2ϩ ] i ϭ 28 Ϯ 4 nM (n ϭ 17 of 17) in neurons pretreated with bafilomycin A 1 and 26 Ϯ 6 nM (n ϭ 33 of 33) in neurons pretreated with rapamycin
Activation of endolysosomal AT 1 R in neurons mobilizes
The ANG II-dependent Ca 2ϩ response in Ca Fig. 5, A and B) .
Hypothalamic neurons depolarize upon stimulation of endolysosomal AT 1 R. Mean resting V m in cultured hypothalamic neurons was Ϫ52.9 Ϯ 0.1 mV (n ϭ 173). Microinjection of control buffer did not modify the neuronal V m (⌬V m ϭ 0.1 Ϯ 0.1 mV, n ϭ 37), whereas intracellular administration of ANG II (10 Ϫ8 M) depolarized 19% of hypothalamic neurons, with a mean amplitude of 3.74 Ϯ 0.14 mV (n ϭ 6 of 31; Fig. 6 ). When the AT 1 R antagonist CV-11947 (10 Ϫ7 M) was coinjected with ANG II, the effect of ANG II was abolished (⌬V m ϭ 0.3 Ϯ 0.11 mV, n ϭ 34 of 34). Conversely, coadministration of the AT 2 R antagonist PD-123319 (10 Ϫ7 M) did not affect the ANG II-induced depolarization (⌬V m ϭ 3.67 Ϯ 0.09 mV, n ϭ 6 of 32; Fig. 6 ). Moreover, inhibition of microautophagy with rapamycin abolished the depolarization produced by ANG II microinjection in hypothalamic neurons (⌬V m ϭ 0.27 Ϯ 0.2 mV, n ϭ 39 of 39; Fig. 6 ). Pretreatment of neurons for 30 min with BAPTA-AM (200 M) prevented the effect of ANG II (⌬V m ϭ 0.27 Ϯ 0.15 mV, n ϭ 71 of 71; Fig. 6 ), indicating that the increase in [Ca 2ϩ ] i is a mandatory step in the ANG II-mediated depolarization. In the presence of SKF-96365 (2 M), which blocks receptor-and store-operated Ca 2ϩ entry via transient receptor potential canonical (TRPC) channels (13, 50) , the response to ANG II was also abolished (⌬V m ϭ 0.21 Ϯ 0.11 mV, n ϭ 94 of 94; Fig. 6 ). Expression of several subtypes of TRPC channels has been documented in the human and rodent hypothalamus (19, 39) .
SKF-96365 (2 M) did not block the Ca 2ϩ elevation in response to KCl (30 mM; Fig. 7 ), which produces depolarization-induced activation of voltage-gated Ca 2ϩ channels; thus, at the concentration tested in this study, SKF-96365 is devoid of inhibitory activity at voltage-gated Ca 2ϩ channels. While diacylglycerol (DAG) has been reported to promote TRPC channel activation downstream of PLC (44), in the present study, the membrane-permeable DAG analog OAG (100 M) (43) had no effect on the resting V m of hypothalamic neurons (Fig. 6) ; as such, DAG is unlikely to be a mediator of ANG II-induced depolarization via TRPC channels.
DISCUSSION
While the presence of an intracellular RAS in neurons has been proposed for four decades (20) , the functional significance of intraneuronal ANG II remained unclear. The effects and signaling pathways of ANG II in the brain have been extensively studied (3, 40, 46, 47) . The contribution of brain ANG II to central control of blood pressure, drinking behavior, and salt appetite is indisputable (46, 47) ; these effects are mainly AT 1 R-mediated (46, 47) .
In light of increasing evidence of the intracrine role of ANG II (14, 17), we used concurrent Ca 2ϩ -imaging and microinjection techniques to assess the role of intracellular ANG II in hypothalamic neurons. Initial experiments in AT 1 R-transfected U2OS cells confirm the validity of our methods and selectivity of receptor antagonists. Our results indicate that intracellular AT 1 R is functional in hypothalamic neurons; microinjection of ANG II produced a dose-dependent increase in [Ca 2ϩ ] i mediated by AT 1 R activation. Roughly 20% of neurons were ANG II-sensitive, indicating that the response may be selective to discrete neuronal populations in hypothalamic nuclei.
In an additional series of experiments, we examined the intracellular location of functional AT 1 R in hypothalamic neurons. We found that disruption of lysosomes, but not the Golgi apparatus, completely prevented the effect of microinjected ANG II. In the absence of reliable anti-AT 1 R antibodies (18, 26) , we examined the distribution of AT 1 R and the endolysosomal-associated small GTPase Rab7 (45) in hypothalamic neurons and identified extensive colocalization, supporting the endolysosomal location of AT 1 R suggested by the functional studies.
Increasing evidence indicates that GPCRs may signal from the endolysosomal compartment (9, 16, 17, 27) . This is not surprising, since the endolysosomal membranes are organized into specialized domains where molecules can assemble into specific signaling complexes (23, 41) . However, the binding pocket for ANG II is situated on the NH 2 -terminal side of the AT 1 R and, thus, within the endolysosomal lumen, a site that is not immediately accessible for peptidic ligands. Nevertheless, we previously demonstrated that ANG II (17) or endothelin-1 (16) applied to the cell cytosol can be readily transferred inside the endolysosomal vesicles via microautophagy, a constitutive process by which soluble substrates are directly engulfed (35) . A similar mechanism seemed plausible in the case of neuronal lysosomes. Indeed, rapamycin, an inhibitor of the last stage of the microautophagic process (30) , prevented the effect of intracellular ANG II in hypothalamic neurons. Interestingly, the response was very fast, while the microautophagic process is expected to occur rather slowly. The time necessary for microautophagy is largely dependent on the lysosomal membrane invagination step of the process, which occurs with a 20-to 30-min lag; the subsequent vesicle scission step is very rapid, occurring in seconds (30, 35) . Given that microautophagy is an ongoing process, important in housekeeping and in maintenance of cytoplasmic mass (35) , membrane invaginations are formed continuously, and cytoplasmic components may be rapidly taken up into the endolysosomal lumen. The microautophagic vesicles, as generated, contain cytoplasmic medium, which is expected to preserve ANG II unmodified. After vesicle scission, hydrolases act to break down the vesicle and release microautophagic components into the lysosomal lumen, while permeases, such as Atg22p, promote recycling of nutrients and energy (35) .
Next, we sought to characterize the signaling pathway triggered by activation of endolysosomal AT 1 R in hypothalamic neurons. Incubation of neurons in Ca (15) ; this pathway is functional in hypothalamic neurons (42) . In addition, PLC is expressed in the endolysosomal membrane (36); we found that PLC inactivation prevents the neuronal response to microinjected ANG II.
Since ANG II modulates hypothalamic function via depolarization and/or increase in excitability of target neurons (2, 10, 34), we further assessed whether intracellular administration of ANG II affects V m in cultured hypothalamic neurons. A subpopulation of tested neurons depolarized in response to microinjected ANG II; the response was AT 1 R-mediated and dependent on microautophagy. The percentage of neurons responding with a change in V m correlated well with the proportion of neurons in which [Ca 2ϩ ] i was elevated in response to ANG II microinjection. Whereas the mean amplitude of the depolarization triggered by microinjected ANG II is rather small (3.74 Ϯ 0.14 mV), it is largely similar to that elicited by the bath-applied peptide in the hypothalamic neurons in the paraventricular nucleus that project to the rostral ventrolateral medulla (11) . This angiotensinergic pathway is involved in blood pressure regulation (47) , endorsing a physiological relevance of the change in V m observed upon endolysosomal AT 1 R activation. Changes in resting V m determine the ease with which excitatory synaptic inputs bring V m closer to the threshold for action potential firing. A ϳ4-mV depolarization of hypothalamic neurons in the paraventricular nucleus was associated with a fourfold increase in the firing frequency of action potential discharge in response to ANG II (11) . Since DiBAC 4 (3) is a slow-response voltage-sensitive dye, fast changes in V m and neuronal firing in response to ANG II microinjection may have been missed in the present study.
ANG II has been shown to depolarize hypothalamic neurons of supraoptic or paraventricular nuclei via activation of nonselective cation channels (31, 48) . Since mobilization of Ca 2ϩ from intracellular stores is a prerequisite for the activation of nonselective cationic conductance (38) , this appeared to be a likely explanation linking the two main events triggered by intracellular ANG II in cultured hypothalamic neurons. Indeed, we noticed that chelation of intracellular Ca 2ϩ with BAPTA-AM abolished the Ca 2ϩ response and the depolarization elicited by ANG II. Furthermore, blocking Ca 2ϩ entry via the TRPC channel, a nonselective cation channel activated via PLC by Ca 2ϩ release from the ER (12, 44) or directly by DAG (44), also abolished the depolarization. In our experimental paradigm, however, DAG seemed not to be involved in TRPC channel activation, since OAG, a DAG analog used to study the existence of DAG-sensitive currents (43), could not mimic ANG II-induced depolarization in hypothalamic neurons.
Corroborating the findings of this study, we propose that, in hypothalamic neurons, intracellular ANG II may reach the AT 1 R in the endolysosomes by microautophagy. ANG II stimulates endolysosomal AT 1 R, leading to PLC activation and IP 3 -dependent Ca 2ϩ release. The release of Ca 2ϩ from the ER, in turn, activates nonselective cation channels, such as TRPC channels, at the plasma membrane, promoting cation entry and neuronal membrane depolarization. The proposed model is summarized in Fig. 8 . Considering the plethora of effects elicited by ANG II in the hypothalamus (46, 47) , our findings increase the understanding of intracrine ANG II signaling in neurons with implications for neuronal physiology.
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